No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
SHCR240719C1000
- 0.35
- 0.000.00%
15min DelayClose Jul 19 11:03 ET
0.35High0.35Low
0.35Open0.35Pre Close20 Volume1 Open Interest1.00Strike Price0.00Turnover0.00%IV-1.46%PremiumJul 19, 2024Expiry Date0.37Intrinsic Value100Multiplier-3DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma3.91Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
News
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Sharecare, Inc. Buyout
Wilmington, Delaware--(Newsfile Corp. - June 27, 2024) - Rigrodsky Law, P.A. is investigating Sharecare, Inc. ("Sharecare") (NASDAQ: SHCR) regarding possible breaches of fiduciary duties and other vio
Express News | Sharecare Inc : Morgan Stanley Raises Target Price to $1.43 From $1.00
Key Takeaways From Sharecare Analyst Ratings
During the last three months, 4 analysts shared their evaluations of Sharecare (NASDAQ:SHCR), revealing diverse outlooks from bullish to bearish.The following table summarizes their recent ratings, sh
Sharecare Is Maintained at Equal-Weight by Morgan Stanley
Sharecare Is Maintained at Equal-Weight by Morgan Stanley
BTIG Maintains Sharecare(SHCR.US) With Hold Rating
BTIG analyst David Larsen maintains $Sharecare(SHCR.US)$ with a hold rating.According to TipRanks data, the analyst has a success rate of 29.4% and a total average return of -11.3% over the past year.
Morgan Stanley Maintains Sharecare(SHCR.US) With Hold Rating, Cuts Target Price to $1.43
Morgan Stanley analyst Craig Hettenbach maintains $Sharecare(SHCR.US)$ with a hold rating, and adjusts the target price from $2 to $1.43.According to TipRanks data, the analyst has a success rate of 5
Comments
Gainers:
• $Clovis Oncology(CLVS.US$ +40.6% (Rubraca significantly improves progression-free survival in first-line maintenance treatment in women with ovarian cancer regardless of their biomarker status in phase 3 athena-mono trial)
• $Dare Bioscience(DARE.US$ +13.61% (Organon and Dar Bioscience have entered into an agreement whereby Organon will license global rights to XACIATO)
• $KULR Technology(KULR.US$ +9.5% (secured a battery sa...
• $Clovis Oncology(CLVS.US$ +40.6% (Rubraca significantly improves progression-free survival in first-line maintenance treatment in women with ovarian cancer regardless of their biomarker status in phase 3 athena-mono trial)
• $Dare Bioscience(DARE.US$ +13.61% (Organon and Dar Bioscience have entered into an agreement whereby Organon will license global rights to XACIATO)
• $KULR Technology(KULR.US$ +9.5% (secured a battery sa...
14
First off, it’s worth pointing out $Digital World Acquisition Corp(DWAC.US$. It’s a special purpose acquisition company (SPAC) set to take Trump’s Truth Social platform public.That’s a social media service that Trump is working on that will reportedly focus on First Amendment rights.With this announcement, any stocks connected to Trump have been soaring higher.
Recent news concerning Trump hotels getting Sharecare Health Security Verified has investors looking to MARK stock.However, there may be some confusion there as $Sharecare(SHCR.US$ is behind the news.
So why are investors turning to $Remark Holdings(MARK.US$ stock instead?It’s due to Remark Holdings being a partial owner of Sharecare.This has investors bypassing SHCR stock in favor of picking up shares of a company above it instead. Remark Holdings operates a workplace artificial intelligence (AI) through its KanKan business.It also holds a few other companies in its portfolio.Sharecare is among them, as well as Bikini.com, and investments in Hollywood to drive brand growth in China. The company’s market cap is $464.622 million.
Recent news concerning Trump hotels getting Sharecare Health Security Verified has investors looking to MARK stock.However, there may be some confusion there as $Sharecare(SHCR.US$ is behind the news.
So why are investors turning to $Remark Holdings(MARK.US$ stock instead?It’s due to Remark Holdings being a partial owner of Sharecare.This has investors bypassing SHCR stock in favor of picking up shares of a company above it instead. Remark Holdings operates a workplace artificial intelligence (AI) through its KanKan business.It also holds a few other companies in its portfolio.Sharecare is among them, as well as Bikini.com, and investments in Hollywood to drive brand growth in China. The company’s market cap is $464.622 million.
4
Read more